483
Jubilant Cadista Pharmaceuticals, Inc.Jubilant Cadista Pharmaceuticals, Inc. – FDA 483, Feb 28, 2020
Record Details
An FDA inspection of Jubilant Cadista Pharmaceuticals, Inc. in Salisbury, MD, revealed significant deficiencies in manufacturing practices, complaint handling, and regulatory reporting. Observations included inadequate procedures to prevent microbial contamination during packaging, failure to properly investigate product complaints, and delayed submission of field alert reports for serious product defects. These issues suggest a lack of control over critical quality processes.
View Company Profile
ID · fdf3097d-13b9-416c-ba5e-0b1cc12c2ece
Other documents for Jubilant Cadista Pharmaceuticals, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.